BRIACELL THERAPEUTICS CORP. Grants Receivable
BRIACELL THERAPEUTICS CORP. (BCTX) had Grants Receivable of $1.10 million as of 2026-04-30, per its 10-Q filed 2026-06-09.
Financial Statements › Notes
us-gaap:GrantsReceivable · last filed 2026-06-09
- 2026-04-30: Grants Receivable $1.10M.
| Period end | Grants Receivable |
|---|---|
| 2026-04-30 | $1.10M 10-Q · filed 2026-06-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |